Key result
In older polypharmacy patients, clinical medication reviews identified an average of 2.5 drug-related problems per patient, with ≥12 medications increasing the risk of ≥5 DRPs (P < .001).
Why the study?
What are the predictive factors for drug-related problems in older polypharmacy primary care patients?
Observational (n=388)
What are the predictive factors for drug-related problems in older polypharmacy primary care patients?
Clinical medication reviews by community pharmacists identify significant drug-related problems in older polypharmacy patients, particularly those on ≥12 medications or with specific comorbidities like asthma, hypertension, and diabetes.
Supports pharmacist-led reviews for DRP detection in older polypharmacy patients; leaves open effects on outcomes and need for prospective trials.
AIMS AND OBJECTIVES: Targeting older patients with predictive factors for drug-related problems (DRPs) could make clinical medication reviews more cost-effective. The aim of this study was to identify the number, type, and potential predictive factors for DRPs in older polypharmacy patients. METHODS: Community pharmacists performed clinical medication reviews and documented DRPs, types of interventions, and their implementation in older patients. RESULTS: Three hundred eighty-eight medication reviews were analyzed, 964 DRPs (average 2.5 ± 1.9), and 1022 interventions (average 2.6 ± 2.0) were identified. The overall implementation rate of interventions was 70.1%, the highest was observed in interventions aiming to resolve the lack of therapy monitoring (86.8%). Patients with ≥12 medications had an increased risk of ≥5 DRPs (P < .001). Asthma was associated with lack of adherence (P = .002), lack of aspirin, statins, and proton pump inhibitors use with additional therapy needed (P = .002-.004). Predictive factors for drug interactions were antihypertensive medications and/or medications with narrow therapeutic index (P < .05). Lack of efficacy was associated with diabetes (P = .006). Nonsteroidal anti-inflammatory drugs were risk factors for inappropriate drug selection (P = .002). Lack of monitoring was associated with hypertension (P = .013), whereas benzodiazepines (P < .001) and aspirin (P = .021) were overused. CONCLUSION: Patients with asthma, hypertension, and diabetes and lack of statin, antithrombotic agent, and/or proton pump inhibitor use were associated with higher risks for DRPs.
No takes yet. Share an insight, caveat, or question.
Kovačević et al. (2017) conducted an observational in Polypharmacy (n=388). Polypharmacy and specific comorbidities was evaluated on Drug-related problems (DRPs). In older polypharmacy patients, clinical medication reviews identified an average of 2.5 drug-related problems per patient, with ≥12 medications increasing the risk of ≥5 DRPs (P < .001).
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: